{
    "Trade/Device Name(s)": [
        "Cobas Integra 400/800 Bilirubin Total",
        "Roche COBAS Integra Bilirubin Total (BIL-T)"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K081193",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951595"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CIG"
    ],
    "Summary Letter Date": "January 16, 2009",
    "Summary Letter Received Date": "December 19, 2008",
    "Submission Date": "December 18, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.1110"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total or direct) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Bilirubin, total"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Cobas Integra 400",
        "Cobas Integra 800"
    ],
    "Method(s)/Technology(ies)": [
        "Diazo method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Cobas Integra 400/800 Bilirubin Total reagent for quantitative measurement of total bilirubin in human serum using the diazo method.",
    "Indications for Use Summary": "In vitro test for the quantitative determination of the total bilirubin concentration in human serum on COBAS Integra systems; measurement aids in diagnosis and treatment of liver, hemolytic hematological, and metabolic disorders including hepatitis and gall bladder block.",
    "fda_folder": "Clinical Chemistry"
}